Recent articles
Filters
Article types
Publication dates
Issues
Expanding the results
Sections

166 - 180 of 182 Items

Review paper2022, apr 8

How to manage radiation-induced dermatitis?

Dorota Kiprian, Agata Szykut-Badaczewska, Agnieszka Gradzińska, Joanna Czuwara, Lidia Rudnicka

Vol 72, No 2 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(2):86-95.
Invited editorial2022, feb 21

Complementary and alternative therapies in oncology

Joanna Kufel-Grabowska, Mikołaj Bartoszkiewicz

Vol 72, No 2 (2022)

Invited editorial

Nowotwory. Journal of Oncology 2022;72(2):135-136.
Pictures in Oncology2022, feb 18

An extrapleural solitary fibrous tumor with low metastatic potential in a young female

Przemysław Jakub Cuber, Tomasz Wojewoda, Wojciech M. Wysocki

Vol 72, No 2 (2022)

Pictures in Oncology

Nowotwory. Journal of Oncology 2022;72(2):130.
Pictures in Oncology2022, feb 14

Synchronous cervical and ovarian cancer detected with 18F-FDG PET/CT examination

Kamila Kaźmierczak, Witold Cholewiński, Anna Filipczuk, Błażej Nowakowski

Vol 72, No 2 (2022)

Pictures in Oncology

Nowotwory. Journal of Oncology 2022;72(2):129.
Research paper (original)2022, feb 14

Dose estimation in patients treated with radiotherapy for SARS-COVID disease based on EPID measurement

Krzysztof Ślosarek, Tomasz Rutkowski, Adam Gądek, Łukasz Sroka, Łukasz Dolla, Roman Rutkowski, Jerzy Jaroszkiewicz

Vol 72, No 2 (2022)

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(2):67-73.
Review paper2022, feb 14

Possibilities of applying a combination of targeted molecular therapies and immunotherapy in NSCLC patients

Magdalena Wójcik-Superczyńska, Tomasz Jankowski, Paweł Krawczyk

Vol 72, No 3 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(3):184-189.
Review paper2022, feb 11

Selected platinum complexes in standard and modern anti-cancer therapies

Anna Kopacz-Bednarska, Teodora Król

Vol 72, No 2 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(2):96-105.
Research paper (original)2022, feb 11

The prognostic value of RDW, NLR and PLR in sequential radio-chemotherapy for advanced lung cancer

Iwona Jabłońska, Marcin Miszczyk, Marcin Goławski, Iwona Dębosz-Suwińska, Rafał Suwiński

Vol 72, No 3 (2022)

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(3):161-166.
Review paper2022, feb 11

The dose no longer plays a paramount role in radiotherapy (oncology), but time apparently does

Bogusław Maciejewski, Krzysztof Składowski

Vol 72, No 2 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(2):80-85.
Research paper (original)2022, feb 10

Sexual Health in breast cancer patients in Poland

Joanna Kufel-Grabowska, Milena Lachowicz, Mikołaj Bartoszkiewicz, Rodryg Ramlau, Daniel Maliszewski, Krzysztof Łukaszuk

Vol 72, No 2 (2022)

Research paper (original)

Nowotwory. Journal of Oncology 2022;72(2):74-79.
Review paper2022, feb 9

Phacomatoses, genetic testing for personalisation of clinical management (part 2)

Anna Kofla-Dłubacz, Andrzej Stawarski, Tomasz Pytrus, Justyna Gil

Vol 72, No 1 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(1):58-64.
Review paper2022, feb 9
Guidelines / Expert consensus2022, feb 9

Consensus on methods of development of clinical practice guidelines in oncology under the auspices of Maria Sklodowska-Curie National Research Institute of Oncology and the Agency for Health Technology Assessment and Tariff System

Jan Walewski, Dominik Dziurda, Mariusz Bidziński, Barbara Bobek-Bilewicz, Marek Dedecjus, Iwona Hus, Beata Jagielska, Jacek Jassem, Andrzej Kawecki, Dariusz Kowalski, Magdalena Krasztel, Maciej Krzakowski, Tomasz Kubiatowski, Piotr Potemski, Radosław Mądry, Piotr Rutkowski, Anna Rychert, Janusz Ryś, Krzysztof Składowski, Rafał Tarnawski, Hanna Tchórzewska-Korba, Andrzej Tysarowski, Piotr J. Wysocki, Roman Topór-Mądry

Vol 72, No 1 (2022)

Guidelines / Expert consensus

Nowotwory. Journal of Oncology 2022;72(1):44-50.
Review paper2022, feb 9

The Poly(ADP-ribose) polymerase inhibitors in pancreatic cancer

Katarzyna Zubik, Julia Talaśka, Dawid Sigorski, Sergiusz Nawrocki

Vol 72, No 1 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(1):34-43.
Review paper2022, feb 9

Off-label use of medicinal products in oncology: exercising due diligence or experimental activity?

Justyna Estera Król-Całkowska, Janusz Jaroszyński

Vol 72, No 1 (2022)

Review paper

Nowotwory. Journal of Oncology 2022;72(1):26-33.